Public Health Archives - Page 9 of 36 - Boston Life Sciences Times

Iterative Health Raises $77 Million to Expand Clinical Research Network

April 30, 2026

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

April 28, 2026

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

April 27, 2026

THIS WEEK'S STORIES

Veradermics Reports Strong Late-Stage Trial Results for Oral Hair Loss Treatment

April 27, 2026

AstraZeneca’s SAPHNELO Approved in U.S. as Self-Injectable Treatment for Lupus

April 27, 2026

Boston Cell Standards Advances Toward FDA Qualification for Cancer Testing Platform

April 27, 2026

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Public Health

Northwell Health Launches National Toolkit to Help Hospitals Address Gun Violence

Illicit Cigarette Trade Surges Across Americas, Study Finds

Physician-Scientist Takes on Seven Global Marathons to Raise Awareness for Food Allergy Research

Study Links Obesity to Cancer Risk Through Organ Growth and Increased Cell Counts

Life Sciences Innovation Takes Center Stage at MassBio’s 2026 State of Possible Conference

Most Read

Merck KGaA Doses First Patient in Phase 3 Lupus Skin Study

Johnson & Johnson Names Ryan Koors Vice President of Investor Relations

Moleculent Raises $20 Million to Expand Functional Profiling Platform

Komodo Health Names Paul Thomas Chief Financial Officer

EDITOR PICKS

Iterative Health Raises $77 Million to Expand Clinical Research Network

Thermo Fisher Opens Bioprocess Design Center in Massachusetts to Speed Biologics Development

Thermo Fisher to Sell Microbiology Unit to Astorg in $1.075 Billion Deal

THIS WEEK'S STORIES

Veradermics Reports Strong Late-Stage Trial Results for Oral Hair Loss Treatment

AstraZeneca’s SAPHNELO Approved in U.S. as Self-Injectable Treatment for Lupus

Boston Cell Standards Advances Toward FDA Qualification for Cancer Testing Platform

POPULAR CATEGORY

ABOUT US

FOLLOW US